MoonLake Immunotherapeutics (MEX:MLTXN) Interest Expense: MXN-181.41 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:MLTXN MoonLake Immunotherapeutics MEX:MLTXN
28 GF Score
Price MXN305.30
! 3 Warning Signs
View Full Analysis

What is MoonLake Immunotherapeutics Interest Expense?

MoonLake Immunotherapeutics MEX:MLTXN 28 Interest Expense is MXN-181.41 Mil as of Jun. 2026. GuruFocus rates MEX:MLTXN with a GF Score™ of 28/100. The stock has 3 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. MoonLake Immunotherapeutics's interest expense for the three months ended in Jun. 2026 was MXN -45.93 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2026 was MXN-181.41 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. MoonLake Immunotherapeutics's Operating Income for the three months ended in Jun. 2026 was MXN -1,075.91 Mil. MoonLake Immunotherapeutics's Interest Expense for the three months ended in Jun. 2026 was MXN -45.93 Mil. MoonLake Immunotherapeutics did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

MoonLake Immunotherapeutics  (MEX:MLTXN) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

MoonLake Immunotherapeutics's Interest Expense for the three months ended in Jun. 2026 was MXN-45.93 Mil. Its Operating Income for the three months ended in Jun. 2026 was MXN-1,075.91 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2026 was MXN1,749.89 Mil.

MoonLake Immunotherapeutics's Interest Coverage for the quarter that ended in Jun. 2026 is calculated as

MoonLake Immunotherapeutics did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

MoonLake Immunotherapeutics Interest Expense Historical Data

* Premium members only.

The historical data trend for MoonLake Immunotherapeutics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MoonLake Immunotherapeutics Interest Expense Chart

MoonLake Immunotherapeutics Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Interest Expense
0.00 0.00 0.00 0.00 -130.51

MoonLake Immunotherapeutics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -38.36 -58.67 -35.90 -40.92 -45.93
MEX:MLTXN
28GF Score
MoonLake Immunotherapeutics MEX:MLTXN
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MoonLake Immunotherapeutics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-181.41 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of MXN-181.41 Mil mean?
MoonLake Immunotherapeutics (MEX:MLTXN) has a Interest Expense of MXN-181.41 Mil as of Jun. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on MoonLake Immunotherapeutics and its competitors.
Is MoonLake Immunotherapeutics' Interest Expense too high?
MoonLake Immunotherapeutics' current Interest Expense is MXN-181.41 Mil. Overall, MoonLake Immunotherapeutics has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does MoonLake Immunotherapeutics' Interest Expense compare to TSHA and INVA?
MoonLake Immunotherapeutics' Interest Expense of MXN-181.41 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on MoonLake Immunotherapeutics and its competitors. MoonLake Immunotherapeutics's current Interest Expense is MXN-181.41 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MoonLake Immunotherapeutics stock overvalued right now?
MoonLake Immunotherapeutics (MEX:MLTXN) has a current Interest Expense of MXN-181.41 Mil. The current Interest Expense is MXN-181.41 Mil. MoonLake Immunotherapeutics' overall GF Score™ is 28/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For MoonLake Immunotherapeutics (MEX:MLTXN), the current Interest Expense is MXN-181.41 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MoonLake Immunotherapeutics Business Description

Other Exchanges MLTX:USA
Address Dorfstrasse 29, Zug, CHE, 6300
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.
28GF Score

Get the complete analysis for MEX:MLTXN

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN305.30
Price